Melt Pharmaceuticals Funding: $24M Raised, Series B (2024)
Melt Pharmaceuticals is based in Nashville, TN. It has raised $24M in total funding. Latest round: Series B. Backed by Harrow, Inc..
Melt Pharmaceuticals funding overview
Melt Pharmaceuticals is based in Nashville, TN. Melt Pharmaceuticals has raised $24M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for Melt Pharmaceuticals runs through 2024; nothing later has been disclosed. Investors on record include Harrow, Inc..
Melt Pharmaceuticals at a glance
Total raised
$24M
Latest round
Series B
Latest round date
April 2024
Headquarters
Nashville, TN
Notable investors
Harrow, Inc.
Frequently asked about Melt Pharmaceuticals funding
How much has Melt Pharmaceuticals raised?
Melt Pharmaceuticals has raised $24M in total disclosed funding across the rounds on record.
Who has invested in Melt Pharmaceuticals?
Harrow, Inc. are named among the investors backing Melt Pharmaceuticals.
What was the latest Melt Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in April 2024.
Where is Melt Pharmaceuticals based?
Melt Pharmaceuticals is based in Nashville, TN.
When did Melt Pharmaceuticals last raise?
The last disclosed Melt Pharmaceuticals round closed in April 2024 at Series B.
Round data for Melt Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Nashville and backer lists below.
